ID Number		2955
Study Type		Engineering & Physics
Model		Using frequentist and Bayesian averaging modeling of non-neoplastic lesion incidence data from the NTP study, we calculated the benchmark doses (BMD) that elicited a 10% response above background (BMD10) and the lower confidence limits on the BMD at 10% extra risk (BMDL10).
Details
Findings		Effects (preliminary results only)
Status		Completed With Publication
Principal Investigator		Environmental Working Group, Washington, DC
Funding Agency		?????
Country		UNITED STATES
References		Uche, UI et al. Environ Health., (2021) 20:84-doi: 10.1186/s12940-021-00768-1 Naidenko, OV JAMA Oncol., (2022) 8(6):1-
Comments